Leukeran (Chlorambucil) with 25 tablets of 2mg

Category

Oncological Drugs

Line

Antineoplastics

Brand

Leukeran

Molecule

Chlorambucil

Presentation

25 tablets of 2 mg

Laboratory

Aspen

Indications

Leukeran (Chlorambucil) is indicated for the treatment of various neoplasms, including chronic lymphocytic leukemia and non-Hodgkin's lymphomas. This medication acts as an alkylating agent, interfering with the growth and reproduction of cancer cells. Its use is particularly relevant in patients with a confirmed diagnosis of these conditions. Additionally, it can be used in cases of autoimmune diseases where controlled immunosuppression is required.

Composition

Each Leukeran tablet contains 2 mg of chlorambucil as the active ingredient. It also contains excipients that facilitate its formulation and stability.

Contraindications

This medication is contraindicated in patients with known hypersensitivity to chlorambucil or any of the excipients. Its use is not recommended in patients with active infections, severe renal or hepatic insufficiency, or during pregnancy and lactation, unless expressly indicated by a physician.

Precautions

Caution should be exercised in patients with a history of hematological diseases, as chlorambucil can cause bone marrow suppression. Regular hematological monitoring is recommended during treatment. It is also important to consider interactions with other medications the patient is using, as well as an assessment of the patient's general health status before initiating treatment.

Storage

Leukeran should be stored in a cool, dry place, at room temperature, out of the reach of children. It is essential to avoid direct light exposure and keep the product in its original sealed container until use.

Prescription required.

Consult your doctor.